MARKET

BNGO

BNGO

Bionano Genomics Inc
NASDAQ
0.8095
+0.0151
+1.90%
Opening 10:21 04/24 EDT
OPEN
0.7900
PREV CLOSE
0.7944
HIGH
0.8099
LOW
0.7900
VOLUME
165.40K
TURNOVER
0
52 WEEK HIGH
8.20
52 WEEK LOW
0.7143
MARKET CAP
49.57M
P/E (TTM)
-0.1189
1D
5D
1M
3M
1Y
5Y
Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing
Bionano Genomics announces results of study comparing optical genome mapping to traditional cytogenetic methods. Optical genome mapping (OGM) can detect structural variants missed by other methods. OGM has the potential to provide a more comprehensive understanding of leukemia subtypes. The study was conducted by researchers at University Medical Center Groningen.
Benzinga · 3h ago
Weekly Report: what happened at BNGO last week (0415-0419)?
Weekly Report · 2d ago
BIONANO GENOMICS INC - DIAGENS RECEIVED CLASS I REGISTRATION AND APPROVAL FOR CO'S OGM REAGENTS FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Reuters · 04/17 12:01
Weekly Report: what happened at BNGO last week (0408-0412)?
Weekly Report · 04/15 10:45
Bionano Announces Publication Showing That OGM Detects Over 1250 Structural Variants, Including 56 Gene Fusions, In Pediatric Leukemia That Were Missed By Whole Genome Sequencing
Study used optical genome mapping to search for genomic variations in pediatric B-cell acute lymphoblastic leukemia. OGM and whole genome sequencing can potentially identify new therapeutic targets and improve personalized medicine in pediatric leukemia and other cancers. Of the 3,075 SVs detected, 1,255 were uniquely detected by OGM.
Benzinga · 04/11 12:16
Weekly Report: what happened at BNGO last week (0401-0405)?
Weekly Report · 04/08 10:50
BioNano Genomics Launches Offering to Bolster Finances
BioNano Genomics Inc has initiated a registered direct offering of over 6.5 million shares and warrants. The company could raise $10 million in gross proceeds. The funds are earmarked for general corporate needs. The offering is set to close in 2024. BNGO stock is down 2.7% today.
TipRanks · 04/05 13:42
Bionano Genomics Expects $10M in Proceeds from Direct Offering
Bionano Genomics agreed to the purchase and sale of its common stock. The San Diego genome analysis solutions provider will purchase and sell about 8.7 million shares. The offering is expected to close on or about April 8. The gross proceeds to the company are expected to be about $10 million.
Dow Jones · 04/04 18:00
More
About BNGO
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Webull offers BioNano Genomics Inc stock information, including NASDAQ: BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNGO stock methods without spending real money on the virtual paper trading platform.